line
Japanese Society for Palliative Medicine
News Letter No.77
日本緩和医療学会ニューズレター
Nov 2017  77
Journal Watch
緩和ケアに関する論文レビュー
名古屋大学大学院 医学系研究科 看護学専攻 基礎・臨床看護学講座  佐藤 一樹
対象雑誌:N Engl J Med, Lancet, Lancet Oncol, JAMA, JAMA Intern Med, BMJ, Ann Intern Med, J Clin Oncol, Ann Oncol, Eur J Cancer, Br J Cancer, Cancer

対象期間:2017年6月〜8月刊行分

いわゆる“トップジャーナル”に掲載された緩和ケアに関する最新論文を広く紹介します。

【N Engl J Med. 2017;376(22-26), 377(1-9)】
1.オランダの終末期医療の1990年〜2015年の推移

van der Heide A, van Delden JJM, Onwuteaka-Philipsen BD. End-of-Life Decisions in the Netherlands over 25 Years. N Engl J Med. 2017;377(5):492-4. PMID 28767342.

【Lancet. 2017;389, 390(10085-10097)】
2.高齢者対象の看取りのケアパスの無作為化比較試験

Beernaert K, Smets T, Cohen J, Verhofstede R, Costantini M, Eecloo K, et al. Improving comfort around dying in elderly people: a cluster randomised controlled trial. Lancet. 2017;390(10090):125-34. PMID 28526493.
3.麻酔導入時のケタミン使用による高齢者の術後せん妄予防の無作為化比較試験
Avidan MS, Maybrier HR, Abdallah AB, Jacobsohn E, Vlisides PE, Pryor KO, et al. Intraoperative ketamine for prevention of postoperative delirium or pain after major surgery in older adults: an international, multicentre, double-blind, randomised clinical trial. Lancet. 2017;390(10091):267-75. PMID 28576285.
4.慢性疲労症候群に対する運動療法と専門的医学支援の無作為化比較試験
Clark LV, Pesola F, Thomas JM, Vergara-Williamson M, Beynon M, White PD. Guided graded exercise self-help plus specialist medical care versus specialist medical care alone for chronic fatigue syndrome (GETSET): a pragmatic randomised controlled trial. Lancet. 2017;390(10092):363-73. PMID 28648402.

【Lancet Oncol. 2017;18(6-8)】
5.成人グリオーマでの緩和ケアのガイドライン:欧州腫瘍学会EANO

Pace A, Dirven L, Koekkoek JAF, Golla H, Fleming J, Ruda R, et al. European Association for Neuro-Oncology (EANO) guidelines for palliative care in adults with glioma. Lancet Oncol. 2017;18(6):e330-e40. PMID 28593859.

【JAMA. 2017;317(21-24), 318(1-8)】
6.慢性腰痛でのNSAIDsの解説

Enthoven WTM, Roelofs PD, Koes BW. NSAIDs for Chronic Low Back Pain. JAMA. 2017;317(22):2327-8. PMID 28609520.
7.慢性腰痛での高周波除神経術の無作為化比較試験
Juch JNS, Maas ET, Ostelo R, Groeneweg JG, Kallewaard JW, Koes BW, et al. Effect of Radiofrequency Denervation on Pain Intensity Among Patients With Chronic Low Back Pain: The Mint Randomized Clinical Trials. JAMA. 2017;318(1):68-81. PMID 28672319.
8.大うつ病に対し抗うつ薬無効の際の抗うつ薬スイッチ法と漸増法の比較
Mohamed S, Johnson GR, Chen P, Hicks PB, Davis LL, Yoon J, et al. Effect of Antidepressant Switching vs Augmentation on Remission Among Patients With Major Depressive Disorder Unresponsive to Antidepressant Treatment: The VAST-D Randomized Clinical Trial. JAMA. 2017;318(2):132-45. PMID 28697253.
9.プレドニゾロン内服高齢者でのアレンドロン酸使用と股関節骨折の関連
Axelsson KF, Nilsson AG, Wedel H, Lundh D, Lorentzon M. Association Between Alendronate Use and Hip Fracture Risk in Older Patients Using Oral Prednisolone. JAMA. 2017;318(2):146-55. PMID 28697254.
10.抗癌治療中の定期的な症状モニタリングと予後との関連(短報)
Basch E, Deal AM, Dueck AC, Scher HI, Kris MG, Hudis C, et al. Overall Survival Results of a Trial Assessing Patient-Reported Outcomes for Symptom Monitoring During Routine Cancer Treatment. JAMA. 2017;318(2):197-8. PMID 28586821.
11.退院後の再入院率と予後との関連
Dharmarajan K, Wang Y, Lin Z, Normand ST, Ross JS, Horwitz LI, et al. Association of Changing Hospital Readmission Rates With Mortality Rates After Hospital Discharge. JAMA. 2017;318(3):270-8. PMID 28719692.
12.成人大腸がんの死亡率:米国での1970年〜2014年の推移(短報)
Siegel RL, Miller KD, Jemal A. Colorectal Cancer Mortality Rates in Adults Aged 20 to 54 Years in the United States, 1970-2014. JAMA. 2017;318(6):572-4. PMID 28787497.
13.慢性痛でのオピオイド処方と処方期間、オピオイド依存治療と過剰摂取との関連(短報)
Frazier W, Cochran G, Lo-Ciganic WH, Gellad WF, Gordon AJ, Chang CH, et al. Medication-Assisted Treatment and Opioid Use Before and After Overdose in Pennsylvania Medicaid. JAMA. 2017;318(8):750-2. PMID 28829862.

【JAMA Intern Med. 2017;177(6-8)】
14.慢性腰痛に対する認知行動療法の自動音声応答電話と人による方法の比較
Heapy AA, Higgins DM, Goulet JL, LaChappelle KM, Driscoll MA, Czlapinski RA, et al. Interactive Voice Response-Based Self-management for Chronic Back Pain: The COPES Noninferiority Randomized Trial. JAMA Intern Med. 2017;177(6):765-73. PMID 28384682.
15.事前ケア計画作成支援ウェブサイトPREPAREの無作為化比較試験
Sudore RL, Boscardin J, Feuz MA, McMahan RD, Katen MT, Barnes DE. Effect of the PREPARE Website vs an Easy-to-Read Advance Directive on Advance Care Planning Documentation and Engagement Among Veterans: A Randomized Clinical Trial. JAMA Intern Med. 2017;177(8):1102-9. PMID 28520838.
16.高齢でのがん検診の意義に関する高齢者の認識
Schoenborn NL, Lee K, Pollack CE, Armacost K, Dy SM, Bridges JFP, et al. Older Adults' Views and Communication Preferences About Cancer Screening Cessation. JAMA Intern Med. 2017;177(8):1121-8. PMID 28604917.
17.認知症患者の痛みと記憶障害の関係に関するコホート研究
Whitlock EL, Diaz-Ramirez LG, Glymour MM, Boscardin WJ, Covinsky KE, Smith AK. Association Between Persistent Pain and Memory Decline and Dementia in a Longitudinal Cohort of Elders. JAMA Intern Med. 2017;177(8):1146-53. PMID 28586818.
18.ナーシングホームでのカテーテル関連尿路感染症予防の米国の国家プロジェクトの効果
Mody L, Greene MT, Meddings J, Krein SL, McNamara SE, Trautner BW, et al. A National Implementation Project to Prevent Catheter-Associated Urinary Tract Infection in Nursing Home Residents. JAMA Intern Med. 2017;177(8):1154-62. PMID 28525923.
19.透析を受けるナーシングホーム療養者での事前指示と延命治療の関係(短報)
Kurella Tamura M, Liu S, Montez-Rath ME, O'Hare AM, Hall YN, Lorenz KA. Persistent Gaps in Use of Advance Directives Among Nursing Home Residents Receiving Maintenance Dialysis. JAMA Intern Med. 2017;177(8):1204-5. PMID 28520863.

【Ann Intern Med. 2017;166(11-12), 167(1-4)】
20.慢性腰痛に対するマインドフルネス・ストレス逓減法のレビュー
Anheyer D, Haller H, Barth J, Lauche R, Dobos G, Cramer H. Mindfulness-Based Stress Reduction for Treating Low Back Pain: A Systematic Review and Meta-analysis. Ann Intern Med. 2017;166(11):799-807. PMID 28437793.
21.慢性腰痛に対するヨガ・運動療法・教育介入の無作為化非劣勢試験
Saper RB, Lemaster C, Delitto A, Sherman KJ, Herman PM, Sadikova E, et al. Yoga, Physical Therapy, or Education for Chronic Low Back Pain: A Randomized Noninferiority Trial. Ann Intern Med. 2017;167(2):85-94. PMID 28631003.
22.長期オピオイド療法の減量・中止時の患者報告アウトカムPROのレビュー
Frank JW, Lovejoy TI, Becker WC, Morasco BJ, Koenig CJ, Hoffecker L, et al. Patient Outcomes in Dose Reduction or Discontinuation of Long-Term Opioid Therapy: A Systematic Review. Ann Intern Med. 2017;167(3):181-91. PMID 28715848.

【J Clin Oncol. 2017;35(16-24)】
23.オピオイド誘発性便秘に対するナルメデジンのプラセボ対照無作為比較試験
Katakami N, Oda K, Tauchi K, Nakata K, Shinozaki K, Yokota T, et al. Phase IIb, Randomized, Double-Blind, Placebo-Controlled Study of Naldemedine for the Treatment of Opioid-Induced Constipation in Patients With Cancer. J Clin Oncol. 2017;35(17):1921-8. PMID 28445097.
24.卵巣がん患者での終末期医療の人種間差
Taylor JS, Rajan SS, Zhang N, Meyer LA, Ramondetta LM, Bodurka DC, et al. End-of-Life Racial and Ethnic Disparities Among Patients With Ovarian Cancer. J Clin Oncol. 2017;35(16):1829-35. PMID 28388292.
25.小児がん・造血幹細胞移植での好中球減少症治療ガイドライン
Lehrnbecher T, Robinson P, Fisher B, Alexander S, Ammann RA, Beauchemin M, et al. Guideline for the Management of Fever and Neutropenia in Children With Cancer and Hematopoietic Stem-Cell Transplantation Recipients: 2017 Update. J Clin Oncol. 2017;35(18):2082-94. PMID 28459614.
26.低所得者対象の乳がんサバイバーケアの無作為化比較試験
Maly RC, Liang LJ, Liu Y, Griggs JJ, Ganz PA. Randomized Controlled Trial of Survivorship Care Plans Among Low-Income, Predominantly Latina Breast Cancer Survivors. J Clin Oncol. 2017;35(16):1814-21. PMID 28418767.
27.米国のがんサバイバーの慢性疾患による経済的影響
Guy GP, Jr., Yabroff KR, Ekwueme DU, Rim SH, Li R, Richardson LC. Economic Burden of Chronic Conditions Among Survivors of Cancer in the United States. J Clin Oncol. 2017;35(18):2053-61. PMID 28471724.
28.米国でのがん患者の症状評価の国民代表値の推計
Jensen RE, Potosky AL, Moinpour CM, Lobo T, Cella D, Hahn EA, et al. United States Population-Based Estimates of Patient-Reported Outcomes Measurement Information System Symptom and Functional Status Reference Values for Individuals With Cancer. J Clin Oncol. 2017;35(17):1913-20. PMID 28426375.
29.乳がん・前立腺がん・大腸がんサバイバーの再発不安に対する認知行動療法の無策化比較試験
van de Wal M, Thewes B, Gielissen M, Speckens A, Prins J. Efficacy of Blended Cognitive Behavior Therapy for High Fear of Recurrence in Breast, Prostate, and Colorectal Cancer Survivors: The SWORD Study, a Randomized Controlled Trial. J Clin Oncol. 2017;35(19):2173-83. PMID 28471726.
30.小児がんサバイバーの長期の二次発がんリスク
Teepen JC, van Leeuwen FE, Tissing WJ, van Dulmen-den Broeder E, van den Heuvel-Eibrink MM, van der Pal HJ, et al. Long-Term Risk of Subsequent Malignant Neoplasms After Treatment of Childhood Cancer in the DCOG LATER Study Cohort: Role of Chemotherapy. J Clin Oncol. 2017;35(20):2288-98. PMID 28530852.
31.性的マイノリティでのがん治療格差改善に関するASCO声明
Griggs J, Maingi S, Blinder V, Denduluri N, Khorana AA, Norton L, et al. American Society of Clinical Oncology Position Statement: Strategies for Reducing Cancer Health Disparities Among Sexual and Gender Minority Populations. J Clin Oncol. 2017;35(19):2203-8. PMID 28368670.
32.進行がん患者のストレスコーピングと予後認識の関係
Nipp RD, Greer JA, El-Jawahri A, Moran SM, Traeger L, Jacobs JM, et al. Coping and Prognostic Awareness in Patients With Advanced Cancer. J Clin Oncol. 2017;35(22):2551-7. PMID 28574777.
33.化学療法誘発性末梢神経障害CIPNと転倒・身体機能・日常生活自立度
Winters-Stone KM, Horak F, Jacobs PG, Trubowitz P, Dieckmann NF, Stoyles S, et al. Falls, Functioning, and Disability Among Women With Persistent Symptoms of Chemotherapy-Induced Peripheral Neuropathy. J Clin Oncol. 2017;35(23):2604-12. PMID 28586243.
34.乳がん術後補助療法のアドヒアランスと身体症状の関連
Smith SG, Sestak I, Howell A, Forbes J, Cuzick J. Participant-Reported Symptoms and Their Effect on Long-Term Adherence in the International Breast Cancer Intervention Study I (IBIS I). J Clin Oncol. 2017;35(23):2666-73. PMID 28661758.
35.乳がん患者の不眠に対する太極拳と認知行動療法の非劣勢試験
Irwin MR, Olmstead R, Carrillo C, Sadeghi N, Nicassio P, Ganz PA, et al. Tai Chi Chih Compared With Cognitive Behavioral Therapy for the Treatment of Insomnia in Survivors of Breast Cancer: A Randomized, Partially Blinded, Noninferiority Trial. J Clin Oncol. 2017;35(23):2656-65. PMID 28489508.
36.包括的な抗癌治療効果評価ツールASCO v1, v2 ESMO-MCBSと質調整生存年QALYの関係
Cheng S, McDonald EJ, Cheung MC, Arciero VS, Qureshi M, Jiang D, et al. Do the American Society of Clinical Oncology Value Framework and the European Society of Medical Oncology Magnitude of Clinical Benefit Scale Measure the Same Construct of Clinical Benefit? J Clin Oncol. 2017;35(24):2764-71. PMID 28574778.
37.NSAIDs使用と大腸がんの生存期間との関連
Hua X, Phipps AI, Burnett-Hartman AN, Adams SV, Hardikar S, Cohen SA, et al. Timing of Aspirin and Other Nonsteroidal Anti-Inflammatory Drug Use Among Patients With Colorectal Cancer in Relation to Tumor Markers and Survival. J Clin Oncol. 2017;35(24):2806-13. PMID 28617623.

【Ann Oncol. 2017;28(6-8)】
38.化学療法誘発性悪心・嘔吐CINVのリスク因子
Dranitsaris G, Molassiotis A, Clemons M, Roeland E, Schwartzberg L, Dielenseger P, et al. The development of a prediction tool to identify cancer patients at high risk for chemotherapy-induced nausea and vomiting. Ann Oncol. 2017;28(6):1260-7. PMID 28398530.
39.がん臨床試験の有害事象の原因の報告の正確さ
Le-Rademacher J, Hillman SL, Meyers J, Loprinzi CL, Limburg PJ, Mandrekar SJ. Statistical controversies in clinical research: Value of adverse events relatedness to study treatment: analyses of data from randomized double-blind placebo-controlled clinical trials. Ann Oncol. 2017;28(6):1183-90. PMID 28184420.
40.若手腫瘍医のバーンアウトに関する欧州の国際的調査
Banerjee S, Califano R, Corral J, de Azambuja E, De Mattos-Arruda L, Guarneri V, et al. Professional burnout in European young oncologists: results of the European Society for Medical Oncology (ESMO) Young Oncologists Committee Burnout Survey. Ann Oncol. 2017;28(7):1590-6. PMID 28449049.
41.抗癌治療中の外来進行期がんでの予後予測ツールの開発
Bourgeois H, Grude F, Solal-Celigny P, Dupuis O, Voog E, Ganem G, et al. Clinical validation of a prognostic tool in a population of outpatients treated for incurable cancer undergoing anticancer therapy: PRONOPALL study. Ann Oncol. 2017;28(7):1612-7. PMID 28472235.
42.進行期肺がん患者の身体活動と倦怠感やQOLとの関連
Dhillon HM, Bell ML, van der Ploeg HP, Turner JD, Kabourakis M, Spencer L, et al. Impact of physical activity on fatigue and quality of life in people with advanced lung cancer: a randomized controlled trial. Ann Oncol. 2017;28(8):1889-97. PMID 28459989.
43.進行期非小細胞肺がん患者の悪液質に対するグレリン受容体作動薬アナモレリンの第V相試験:ROMANA3
Currow D, Temel JS, Abernethy A, Milanowski J, Friend J, Fearon KC. ROMANA 3: a phase 3 safety extension study of anamorelin in advanced non-small-cell lung cancer (NSCLC) patients with cachexia. Ann Oncol. 2017;28(8):1949-56. PMID 28472437.
44.がん患者の貧血と体重減少に対するクレアチンの無作為化比較試験
Jatoi A, Steen PD, Atherton PJ, Moore DF, Rowland KM, Le-Lindqwister NA, et al. A double-blind, placebo-controlled randomized trial of creatine for the cancer anorexia/weight loss syndrome (N02C4): an Alliance trial. Ann Oncol. 2017;28(8):1957-63. PMID 28475678.
45.がん診断後の初発の精神障害と予後との関連
Zhu J, Fang F, Sjolander A, Fall K, Adami HO, Valdimarsdottir U. First-onset mental disorders after cancer diagnosis and cancer-specific mortality: a nationwide cohort study. Ann Oncol. 2017;28(8):1964-9. PMID 28525559.
46.乳がん術後補助療法のアドヒアランスと社会経済的指標との関連
Kuijer A, Verloop J, Visser O, Sonke G, Jager A, van Gils CH, et al. The influence of socioeconomic status and ethnicity on adjuvant systemic treatment guideline adherence for early-stage breast cancer in the Netherlands. Ann Oncol. 2017;28(8):1970-8. PMID 28459994.

【Eur J Cancer. 2017;78-81】
47.病院ごとの進行期食道がん診療数と生存期間の関係
Haj Mohammad N, Bernards N, van Putten M, Lemmens V, van Oijen MGH, van Laarhoven HWM. Volume-outcome relation in palliative systemic treatment of metastatic oesophagogastric cancer. Eur J Cancer. 2017;78:28-36. PMID 28412586.
48.中咽頭がんサバイバーのQOL評価のシステマティックレビュー
Hoxbroe Michaelsen S, Gronhoj C, Hoxbroe Michaelsen J, Friborg J, von Buchwald C. Quality of life in survivors of oropharyngeal cancer: A systematic review and meta-analysis of 1366 patients. Eur J Cancer. 2017;78:91-102. PMID 28431302.
49.進行乳がんの骨標的治療のドイツでの実態調査
Schroder J, Fietz T, Kohler A, Petersen V, Tesch H, Spring L, et al. Treatment and pattern of bone metastases in 1094 patients with advanced breast cancer - Results from the prospective German Tumour Registry Breast Cancer cohort study. Eur J Cancer. 2017;79:139-48. PMID 28494404.
50.進行期胃・食道がん入院患者での終末期の化学療法と栄養療法
Kempf E, Tournigand C, Rochigneux P, Aubry R, Morin L. Discrepancies in the use of chemotherapy and artificial nutrition near the end of life for hospitalised patients with metastatic gastric or oesophageal cancer. A countrywide, register-based study. Eur J Cancer. 2017;79:31-40. PMID 28458120.

【Br J Cancer. 2017;116(11-12), 117(1-4)】
51.頭頚部がんでの早期からの予防的経管栄養法の無策化比較試験
Brown TE, Banks MD, Hughes BGM, Lin CY, Kenny LM, Bauer JD. Randomised controlled trial of early prophylactic feeding vs standard care in patients with head and neck cancer. Br J Cancer. 2017;117(1):15-24. PMID 28535154.
52.虚弱高齢者のスクリーニング:高齢者総合的機能評価と臨床医の判断の比較
Kirkhus L, Saltyte Benth J, Rostoft S, Gronberg BH, Hjermstad MJ, Selbaek G, et al. Geriatric assessment is superior to oncologists' clinical judgement in identifying frailty. Br J Cancer. 2017;117(4):470-7. PMID 28664916.

【Cancer. 2017;123(11-16)】
53.初期浸潤性乳がん患者の報告による治療関連有害事象
Friese CR, Harrison JM, Janz NK, Jagsi R, Morrow M, Li Y, et al. Treatment-associated toxicities reported by patients with early-stage invasive breast cancer. Cancer. 2017;123(11):1925-34. PMID 28117882.
54.化学療法誘発性末梢神経障害CIPNに対するニューロフィードバックの無作為化比較試験
Prinsloo S, Novy D, Driver L, Lyle R, Ramondetta L, Eng C, et al. Randomized controlled trial of neurofeedback on chemotherapy-induced peripheral neuropathy: A pilot study. Cancer. 2017;123(11):1989-97. PMID 28257146.
55.アフリカ系米国人の乳がん患者での症状と化学療法のアドヒアランスの関連
Yee MK, Sereika SM, Bender CM, Brufsky AM, Connolly MC, Rosenzweig MQ. Symptom incidence, distress, cancer-related distress, and adherence to chemotherapy among African American women with breast cancer. Cancer. 2017;123(11):2061-9. PMID 28199006.
56.脳転移の全脳照射と定位放射線治療の選択に関する医療者調査
Sandler KA, Shaverdian N, Cook RR, Kishan AU, King CR, Yang I, et al. Treatment trends for patients with brain metastases: Does practice reflect the data? Cancer. 2017;123(12):2274-82. PMID 28178376.
57.切除可能乳がん患者のがん以外の死因による死亡の生存期間への影響
Fu J, Wu L, Jiang M, Li D, Jiang T, Fu W, et al. Real-world impact of non-breast cancer-specific death on overall survival in resectable breast cancer. Cancer. 2017;123(13):2432-43. PMID 28267199.
58.ユーイング肉腫サバイバーの長期的な生存と治療関連慢性疾患
Marina NM, Liu Q, Donaldson SS, Sklar CA, Armstrong GT, Oeffinger KC, et al. Longitudinal follow-up of adult survivors of Ewing sarcoma: A report from the Childhood Cancer Survivor Study. Cancer. 2017;123(13):2551-60. PMID 28222219.
59.大腸がんスクリーニング啓発の市民による教育効果の無作為化比較試験
Jo AM, Nguyen TT, Stewart S, Sung MJ, Gildengorin G, Tsoh JY, et al. Lay health educators and print materials for the promotion of colorectal cancer screening among Korean Americans: A randomized comparative effectiveness study. Cancer. 2017;123(14):2705-15. PMID 28440872.
60.AYA世代がん患者での医療アドヒアランスに対する経済的影響
Kaul S, Avila JC, Mehta HB, Rodriguez AM, Kuo YF, Kirchhoff AC. Cost-related medication nonadherence among adolescent and young adult cancer survivors. Cancer. 2017;123(14):2726-34. PMID 28542734.
61.カルチノイド症候群を有する神経内分泌腫瘍患者でのセロトニン作動薬の認容性の後ろ向き調査
Shi DD, Yuppa DP, Dutton T, Brais LK, Minden SL, Braun IM, et al. Retrospective review of serotonergic medication tolerability in patients with neuroendocrine tumors with biochemically proven carcinoid syndrome. Cancer. 2017;123(14):2735-42. PMID 28267211.
62.AYA世代がんサバイバーの長期的な社会機能低下のリスク因子
Husson O, Zebrack BJ, Aguilar C, Hayes-Lattin B, Cole S. Cancer in adolescents and young adults: Who remains at risk of poor social functioning over time? Cancer. 2017;123(14):2743-51. PMID 28319256.
63.乳がんサバイバーの治療後の身体活動の長期的な軌跡
Lucas AR, Levine BJ, Avis NE. Posttreatment trajectories of physical activity in breast cancer survivors. Cancer. 2017;123(14):2773-80. PMID 28272835.
64.乳がん術後補助療法を受けるに値する治療効果に関する患者と医師の認識
Vaz-Luis I, O'Neill A, Sepucha K, Miller KD, Baker E, Dang CT, et al. Survival benefit needed to undergo chemotherapy: Patient and physician preferences. Cancer. 2017;123(15):2821-8. PMID 28323331.
65.国の環境質とがん罹患の関係
Jagai JS, Messer LC, Rappazzo KM, Gray CL, Grabich SC, Lobdell DT. County-level cumulative environmental quality associated with cancer incidence. Cancer. 2017;123(15):2901-8. PMID 28480506.
66.がん医療の患者満足度の要因:デンマークでの調査
Heerdegen ACS, Petersen GS, Jervelund SS. Determinants of patient satisfaction with cancer care delivered by the Danish healthcare system. Cancer. 2017;123(15):2918-26. PMID 28464268.
67.医療資源の乏しい小児病院での小児早期警告システムPEWS導入の効果
Agulnik A, Mora Robles LN, Forbes PW, Soberanis Vasquez DJ, Mack R, Antillon-Klussmann F, et al. Improved outcomes after successful implementation of a pediatric early warning system (PEWS) in a resource-limited pediatric oncology hospital. Cancer. 2017;123(15):2965-74. PMID 28440868.
68.マウンドフルネスストレス逓減法による化学療法中のコルチゾール鈍麻の減少
Black DS, Peng C, Sleight AG, Nguyen N, Lenz HJ, Figueiredo JC. Mindfulness practice reduces cortisol blunting during chemotherapy: A randomized controlled study of colorectal cancer patients. Cancer. 2017;123(16):3088-96. PMID 28387949.
69.閉経後乳がん患者での診断前の抑うつと予後との関連
Liang X, Margolis KL, Hendryx M, Reeves K, Wassertheil-Smoller S, Weitlauf J, et al. Effect of depression before breast cancer diagnosis on mortality among postmenopausal women. Cancer. 2017;123(16):3107-15. PMID 28387934.

Close